Evidence map›Paper›PMID 41573062›Full record

ArticleNorthern clinics of Istanbul2025

Aggravation of lower urinary tract symptoms in patients with benign prostatic hyperplasia after COVID-19.

Ahmet Sanli, Guven Erbay, Ufuk Yavuz, Harun Turel, Hasan Samet Gungor

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Northern clinics of Istanbul, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Ahmet SanliDepartment of Urology, Karamanoglu Mehmetbey University Faculty of Medicine, Karaman, Turkiye.
Guven ErbayDepartment of Urology, Karamanoglu Mehmetbey University Faculty of Medicine, Karaman, Turkiye.
Ufuk YavuzDepartment of Urology, Karamanoglu Mehmetbey University Faculty of Medicine, Karaman, Turkiye.
Harun TurelDepartment of Urology, Karaman Training and Research Hospital, Karaman, Turkiye.
Hasan Samet GungorDepartment of Urology, Umraniye Training and Research Hospital, Istanbul, Turkiye.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveTo evaluate the effects of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) on prostate volume, prostate-specific antigen (PSA) values, International Prostate Symptom Score (IPSS), maximum urinary flow rate (Q

methodsAfter retrospectively review the hospital database, the study included 104 patients aged 40-75 years, who were detected to have SARS-CoV-2 according to the reverse transcription-polymerase chain reaction (RT-PCR) test of combined oro-nasopharyngeal swab samples between March 2020 and December 2020 who were being followed for BPH and had undergone prostate volume, PSA, IPSS, Q

resultsThe prostate volume, PSA, IPSS, Q

conclusionCOVID-19 appears to have a negative impact on IPSS, Q

Indexed as

Benign prostatic hyperplasiaCOVID-19lower urinary tract symptomsSARS-CoV-2urinary tract

Identifiers

PMID41573062
PMCPMC12821111

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.